Physician profile
Emily E Brown
NPI 1851761381
$1,678.90
in general payments reported to CMS, 2019-2025
15 companies · $480 in 2025
The $480 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $371 · 2022: $26.50 · 2023: $355 · 2024: $447 · 2025: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,281.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $214.70 | 2023-2025 | |
| Edwards Lifesciences Corporation | $182.07 | 2025 | Sapien 3 Ultra Resilia |
| Abbvie INC. | $152.95 | 2023-2024 | |
| Boston Scientific Corporation | $150.21 | 2021-2022 | |
| Astellas Pharma US INC | $125.00 | 2023 | Cresemba |
| Alkermes, INC. | $125.00 | 2021 | |
| Alexion Pharmaceuticals, INC. | $121.84 | 2021 | |
| Lilly USA, LLC | $109.96 | 2024 | Mounjaro |
| Impel Pharmaceuticals INC. | $96.94 | 2023 | Trudhesa |
| Lexicon Pharmaceuticals, INC. | $90.72 | 2024 | Inpefa |
| Neurelis, INC. | $90.16 | 2024 | Valtoco |
| Merck Sharp & Dohme LLC | $78.61 | 2024-2025 | Keytruda, Lynparza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.19 | 2025 | Jardiance |
| Lundbeck LLC | $47.50 | 2025 | Rexulti |
| Medtronic, INC. | $15.05 | 2023 | V-Loc 180 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.